InvestorsHub Logo
Followers 56
Posts 2701
Boards Moderated 0
Alias Born 02/01/2017

Re: hoffmann6383 post# 620742

Monday, 08/14/2023 4:38:23 PM

Monday, August 14, 2023 4:38:23 PM

Post# of 702481
Good point Hoffman. Perhaps there were more patients in Q2 who were treated under the specials program and the profit went to Advent and not to NWBO. Furthermore, isn't it possible that DCVax-L prepared via the Flaskworks/Eden method was utilized to treat patients who were exempt from payment because that automatic vaccine production method was still being tested and it would therefore be unethical to charge the patients? This would be a logical way to test the efficacy of the automatic methodology while treating patients at no charge IMHO.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News